OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?
Amazon vs. Costco: Which Stock Is a Better Buy?

Amazon vs. Costco: Which Stock Is a Better Buy?

Cross Staff Loads Up on 289,000 Shares of AKRE

Cross Staff Loads Up on 289,000 Shares of AKRE

Prediction: This Artificial Intelligence (AI) Stock Will Join Nvidia, Apple, and Alphabet in the $3 Trillion Club Before 2028

The billion-dollar infrastructure deals powering the AI boom

AI Boom May Be Creating Hidden Risks In Housing Market

Cisco’s Secure AI Factory Links Sovereign Data Push To Valuation Story

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds

Forget 5G. This Is the Technology Apple Is Really Betting On With the iPhone 12.

November 9, 2020

Apple (NASDAQ: AAPL) hasn't yet introduced an augmented reality (AR) device or even promised one, as Facebook has, but it recently took steps to build the most...

3rdPartyFeeds • News

Tech Stocks: Zoom, Peloton, Etsy lead stay-at-home tech selloff after upbeat Pfizer vaccine announcement

November 9, 2020

Shares of technology stocks that saw big benefits from stay-at-home trends due to the pandemic are falling in morning trading Monday given upbeat vaccine news...

3rdPartyFeeds

Lockdown Winners Fade as Reopen Trade Roars After Covid Data

November 9, 2020

(Bloomberg) -- Investors cashed out of companies that benefited from virus-induced lockdowns after promising results for a Covid-19 vaccine developed by Pfizer...

3rdPartyFeeds

Dow Jones Today, Stock Futures Spike 1,500 Points On Biden Presidency, Pfizer Vaccine News

November 9, 2020

The Dow Jones today soared more than 1,500 points, Pfizer and BioNTech spiked on coronvirus vaccine news as markets valued in a Joe Biden presidency. Read More...

3rdPartyFeeds

Dow Jones Futures Surge As Pfizer/BioNTech Coronavirus Vaccine Effective, Tech Futures Slash Gains In Market Rally Shakeup

November 9, 2020

Dow futures soared as a Pfizer/BioNTech coronavirus vaccine is over 90% effective. But tech futures slashed gains. Read More...

3rdPartyFeeds • News

Need to Know: A strong year-end rally lies ahead. It’s time to rotate ‘within the tech sector’ — away from FAANG stocks, strategist says

November 9, 2020

U.S. stocks look set to continue their rally after former Vice President Joe Biden declared victory in the election, and as Pfizer said its vaccine candidate...

3rdPartyFeeds

5 Questions to Ask Yourself Before Buying Any Stock

November 9, 2020

It's smart -- and it can be extremely profitable -- to invest in stocks. But don't jump in until you're ready. Read More...

3rdPartyFeeds

McDonald’s earnings top estimates, fueled by U.S. sales recovery

November 9, 2020

Shares of McDonald's, which has a market value of $167 billion, have risen 9% so far this year. Read more...

3rdPartyFeeds • News

: Airline stocks blast off after upbeat news on potential COVID-19 vaccine

November 9, 2020

Shares of airline companies blasted off Monday, after upbeat news on a potential COVID-19 vaccine candidate from Pfizer Inc. and BioNTech SE gave investors...

3rdPartyFeeds

Canopy Growth Soars on Narrower-Than-Expected Loss

November 9, 2020

Canopy Growth posts a narrower-than-expected fiscal second-quarter loss and revenue that topped forecasts. Read More...

Previous 1 … 5,369 5,370 5,371 5,372 5,373 … 8,454 Next
Indices by TradingView

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.